Initial testing with an adjunct recombinant IL-12 with CEA-CAR T cells showed enhanced CAR T cell activation and cytotoxicity in vitro with tumor growth inhibition and CAR T cell proliferation in colorectal, pancreatic, and gastric murine models than CEA CAR T cells alone (Table 1) [62]. Here, CEACAM5 is linked to neoplasm.